EV
EVIO, Inc.
EVIO · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 25.14%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
Asset turnover N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Debt/Assets N/A
Stability
66 /100
Moderate Beta -2.39x
Rev. volatility 16.41%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EVIO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Lori Jean Glauser
Employees
18
Headquarters
Henderson